The implications and requirements of transcatheter aortic valve replacement in low-risk patients
Transcatheter aortic valve replacement (TAVR) is a transformative technology that has changed the management of patients with severe, symptomatic aortic stenosis. The use of TAVR in intermediate- to high-risk patients has been validated in several rigorously performed, randomized clinical trials. Re...
Main Authors: | Emin Murat Tuzcu, Ahmad Edris |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-12-01
|
Series: | Anatolian Journal of Cardiology |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=anatoljcardiol&un=AJC-39293 |
Similar Items
-
Transcatheter aortic valve replacement: clinical researches and progress of application
by: JIN Jun
Published: (2019-10-01) -
Comparing Trajectory of Surgical Aortic Valve Replacement in the Early vs. Late Transcatheter Aortic Valve Replacement Era
by: Gabby Elbaz-Greener, et al.
Published: (2021-06-01) -
Transcatheter aortic valve replacement in patients with bicuspid aortic valve stenosis: national trends and in-hospital outcomes
by: Mohamad Soud, et al.
Published: (2020-01-01) -
Will Transcatheter Aortic Valve Replacement (TAVR) be the Primary Therapy for Aortic Stenosis?
by: Jose F. Condado, MD, MS, et al.
Published: (2016-05-01) -
Transcatheter Aortic Valve Replacement in Female Patients—Present Scenario
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2017-09-01)